EDIT – Editas Medicine Inc

Editas Medicine, Inc. 于2013年9月以Gengine, Inc.名字成立,后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司,致力于通过纠正患者的致病基因治疗与基因相关的疾病。

中文介绍: https://xueqiu.com/S/EDIT

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company only operating segment being developing and commercializing genome editing technology.

英文介绍: https://www.morningstar.com/stocks/xnas/edit/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/edit-editas-medicine-inc/

发表评论

邮箱地址不会被公开。 必填项已用*标注